HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

15d-PGJ2-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice.

Abstract
Gout arthritis (GA) is a painful inflammatory disease in response to monosodium urate (MSU) crystals in the joints. 15deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) is a natural activator of PPAR-γ with analgesic, anti-inflammatory, and pro-resolution properties. Thus, we aimed to evaluate the effect and mechanisms of action of 15d-PGJ2 nanocapsules (NC) in the model of GA in mice, since a reduction of 33-fold in the dose of 15d-PGJ2 has been reported. Mice were treated with 15d-PGJ2-loaded NC, inert NC, free 15d-PGJ2 (without NC), or 15d-PGJ2-loaded NC+ GW9662, a PPAR-γ inhibitor. We show that 15d-PGJ2-loaded NC provided analgesic effect in a dose that the free 15d-PGJ2 failed to inhibiting pain and inflammation. Hence, 15d-PGJ2-loaded NC reduced MSU-induced IL-1β, TNF-α, IL-6, IL-17, and IL-33 release and oxidative stress. Also, 15d-PGJ2-loaded NC decreased the maturation of IL-1β in LPS-primed BMDM triggered by MSU. Further, 15d-PGJ2-loaded NC decreased the expression of the components of the inflammasome Nlrp3, Asc, and Pro-caspase-1, as consequence of inhibiting NF-κB activation. All effects were PPAR-γ-sensitive. Therefore, we demonstrated that 15d-PGJ2-loaded NC present analgesic and anti-inflammatory properties in a PPAR-γ-dependent manner inhibiting IL-1β release and NF-κB activation in GA. Concluding, 15d-PGJ2-loaded NC ameliorates MSU-induced GA in a PPAR-γ-sensitive manner.
AuthorsKenji W Ruiz-Miyazawa, Larissa Staurengo-Ferrari, Felipe A Pinho-Ribeiro, Victor Fattori, Tiago H Zaninelli, Stephanie Badaro-Garcia, Sergio M Borghi, Ketlem C Andrade, Juliana T Clemente-Napimoga, Jose C Alves-Filho, Thiago M Cunha, Leonardo F Fraceto, Fernando Q Cunha, Marcelo H Napimoga, Rubia Casagrande, Waldiceu A Verri Jr
JournalScientific reports (Sci Rep) Vol. 8 Issue 1 Pg. 13979 (09 18 2018) ISSN: 2045-2322 [Electronic] England
PMID30228306 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 15-deoxyprostaglandin J2
  • Antioxidants
  • Nanocapsules
  • PPAR gamma
  • Uric Acid
  • Prostaglandin D2
Topics
  • Animals
  • Antioxidants (toxicity)
  • Arthritis, Experimental (metabolism, pathology, prevention & control)
  • Arthritis, Gouty (metabolism, pathology, prevention & control)
  • Inflammation (chemically induced, drug therapy, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nanocapsules (administration & dosage)
  • Oxidative Stress
  • PPAR gamma (metabolism)
  • Pain (chemically induced, drug therapy, metabolism)
  • Prostaglandin D2 (analogs & derivatives, pharmacology)
  • Uric Acid (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: